H2AX and ovarian cancer: However, little is known about the expression and role of γ-H2Ax in circulating ovarian cancer-associated cells (CC) from blood (‘liquid biopsies’), although evidence of γ-H2AX expression exists in CC from Stage IV breast cancer patients undergoing platinum therapy [14].